MRNA

Moderna, Inc. is a pioneering biotechnology company based in Cambridge, Massachusetts, recognized for its innovative approach to messenger RNA (mRNA) technology in vaccine and therapeutic development. Gaining global prominence for its role in delivering one of the first successful COVID-19 vaccines, Moderna is now strategically expanding its portfolio to target a wide array of health challenges, including immuno-oncology, rare diseases, cardiovascular conditions, and autoimmune disorders. With a commitment to advancing healthcare through cutting-edge research and a strong product pipeline, Moderna seeks to redefine the future of medicine and address unmet medical needs on a global scale.